Medacta Group S.A.
Medacta Group S.A. Fundamental Analysis
Medacta Group S.A. (MOVE.SW) shows moderate financial fundamentals with a PE ratio of 35.15, profit margin of 13.96%, and ROE of 21.69%. The company generates $0.7B in annual revenue with strong year-over-year growth of 15.62%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 72.5/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze MOVE.SW's fundamental strength across five key dimensions:
Efficiency Score
ExcellentMOVE.SW demonstrates superior asset utilization.
Valuation Score
WeakMOVE.SW trades at a premium to fair value.
Growth Score
ExcellentMOVE.SW delivers strong and consistent growth momentum.
Financial Health Score
ExcellentMOVE.SW maintains a strong and stable balance sheet.
Profitability Score
ModerateMOVE.SW maintains healthy but balanced margins.
Key Financial Metrics
Is MOVE.SW Expensive or Cheap?
P/E Ratio
MOVE.SW trades at 35.15 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, MOVE.SW's PEG of 30.84 indicates potential overvaluation.
Price to Book
The market values Medacta Group S.A. at 7.36 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 16.23 times EBITDA. This signals the market has high growth expectations.
How Well Does MOVE.SW Make Money?
Net Profit Margin
For every $100 in sales, Medacta Group S.A. keeps $13.96 as profit after all expenses.
Operating Margin
Core operations generate 16.90 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.69 in profit for every $100 of shareholder equity.
ROA
Medacta Group S.A. generates $10.42 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Medacta Group S.A. produces operating cash flow of $150.49M, showing steady but balanced cash generation.
Free Cash Flow
Medacta Group S.A. produces free cash flow of $29.25M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.47 in free cash annually.
FCF Yield
MOVE.SW converts 0.89% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
35.15
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
30.84
vs 25 benchmark
P/B Ratio
Price to book value ratio
7.36
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.86
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.58
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.08
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.22
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.17
vs 25 benchmark
How MOVE.SW Stacks Against Its Sector Peers
| Metric | MOVE.SW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 35.15 | 28.54 | Worse (Expensive) |
| ROE | 21.69% | 738.00% | Weak |
| Net Margin | 13.96% | -43982.00% (disorted) | Strong |
| Debt/Equity | 0.58 | 0.34 | Weak (High Leverage) |
| Current Ratio | 2.08 | 2806.01 | Strong Liquidity |
| ROA | 10.42% | -14624.00% (disorted) | Strong |
MOVE.SW outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Medacta Group S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
90.17%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
514.73%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
151.35%
Industry Style: Defensive, Growth, Innovation
High Growth